We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Severe Hantavirus Disease Associated with Low Serum TGF-β Levels

By LabMedica International staff writers
Posted on 27 Apr 2015
Hantaviruses are emerging zoonotic pathogens which cause hemorrhagic fever with renal syndrome, an immune-mediated pathogenesis, and the role of transforming growth factor-β (TGF-β) expression in acute Hantavirus infection has been investigated. More...


TGF-β has a pivotal function in the immune system and controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis, activation, and survival of lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes.

Scientists at the University of Heidelberg (Germany) and their colleagues retrospectively studied 77 patients hospitalized with acute Puumala virus infection during a Hantavirus epidemic in Germany in 2012. The mean age of patients was 40.8 years, 52 were male (68%), five (6%) were under the age of 18 years. Polymerase chain reaction (PCR) for the detection of Hantavirus ribonucleic acid (RNA) was performed on the L-segment.

Sera were tested for Hantavirus immunoglobulin G (IgG) and IgM antibodies using the recomLine Hantavirus assay (Mikrogen; Munich, Germany), coated with specific Hantavirus nucleocapsid antigens of Puumala virus, Dobrava-Belgrade virus, Hantaan virus, and Seoul virus. TGF-β1, β2 and β3 were measured with the Luminex TGF assay (R&D Systems, Wiesbaden, Germany). All cytokines, neopterin and C-reactive protein (CRP) were determined on admission of the patients to the hospital and one week after admission.

Puumala virus RNA was detectable in 4/77 cases. Patients with severe disease had a significant longer hospital stay than patients with mild disease (6.2 days versus 3.6 days). Thrombocyte count 186/nL versus 225/nL), serum TGF-β1 (74 ng/L versus 118 ng/L) and TGF-β2 (479 pg/L versus 586 pg/L) were significantly lower in severe compared to mild disease. However, CRP was significantly higher in patients with severe disease (62 mg/L versus 40 mg/L). TGF-β1/Cr ratio was the most sensitive and specific marker associated with renal dysfunction.

The authors concluded that measurement of TGF-βs and especially TGF-βs/Cr ratios in the early phase of Puumala Hantavirus infection are very sensitive markers of kidney damage and that high expression of TGF-β1 and TGF-β2 are associated with milder courses of Hantavirus infection. High CRP is a marker of disease severity in Hantavirus infection. The results support the hypothesis of an immune-mediated pathogenesis of Hantavirus infection. The study was published on April 14, 2015, in the journal BMC Immunology.

Related Links:

University of Heidelberg 
Mikrogen 
R&D Systems 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.